You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -96.8% | -137.6% |
ROCE | 1,632.2% |
Latest | Forecast | |
---|---|---|
P/E | -4.8 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 7.0 | 6.6 |
Price / Book value | 7.5 |
Latest | Forecast | |
---|---|---|
Revenue | 140.8% | -3.5% |
PBT | 0.0% | n/a |
EPS | 0.0% | -23.9% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 5.51 | -18.05 | -12.98p | -1.3 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 2.14 | -18.86 | -7.27p | -15.7 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 2.94 | -29.19 | -10.57p | -12.0 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 9.65 | -41.64 | -14.48p | -7.9 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 23.25 | -27.32 | -9.15p | -12.7 | 0.0 | n/a | n/a | 0.0% |
Avacta Group appoints new non-executive chair Sharecast News | 20 Jun |
---|---|
Avacta reports further progress in chemotherapy trial Sharecast News | 23 May |
Avacta reaches milestone in AVA6000 dose escalation Sharecast News | 21 Mar |
R&D Spotlight focusing on pipeline advances | 30-Oct-24 07:01 |
---|---|
Block Listing Six Monthly Return | 28-Oct-24 07:01 |
Avacta Reports Pipeline Avances at EORTC | 24-Oct-24 07:01 |
Issue of Equity and Total Voting Rights | 21-Oct-24 16:00 |
Avacta and Tempus Enter Strategic Collaboration | 21-Oct-24 07:01 |